Pharmafile Logo
Pharmafocus logo
Advanced Search

Allergan marketing breaches discredited industry

March 22, 2011
Medical Communications Allergan, Cephalon, PMCPA

Allergan, the manufacturer of Botox, has been censured for several breaches of the ABPI Code of Practice. The PMCPA watchdog …

News

Novartis gets FDA warning letter for Puerto Rico plant

March 21, 2011
Manufacturing and Production Ciba Vision, FDA manufacturing inspections, Novartis, SoftPerm contact lenses, manufacturing compliance, pharma manufacturing

A manufacturing facility operated by Novartis subsidiary Ciba Vision in Puerto Rico has been cited for manufacturing quality violations and …

News

GSK Parkinson’s drug impresses at phase III

March 21, 2011
Research and Development ADVANCE-PD, GSK, GlaxoSmithKline, IPX066, Impax Pharmaceuticals, Parkinson's disease, Parkinson’s disease

GlaxoSmithKline’s advanced Parkinson’s disease drug IPX066 has impressed in a head to head trial against it nearest rival. The phase …

News
Sanofi-Aventis HQ

Sanofi prostate cancer drug Jevtana approved in Europe

March 21, 2011
Sales and Marketing Jevtana, Sanofi-Aventis, TROPIC clinical trial, cabazitaxel, cancer drugs, chemotherapy, prostate cancer

Sanofi-Aventis’ new chemotherapy treatment Jevtana has followed up on its US approval last year by receiving the green light in …

News
Novartis headquarters

First oral MS pill approved in Europe

March 21, 2011
Sales and Marketing MS, Novaris, fingolimod, first oral multiple sclerosis drug, gilenya, multiple sclerosis

Novartis’ Gilenya has become the first oral multiple sclerosis drug to be approved in Europe. Gilenya (fingolimod) is now licensed …

News

Guy Blomfield joins Alliance Medical Group

March 21, 2011
Sales and Marketing appointment, sales and marketing

European diagnostic imaging company Alliance Medical Group has appointed Guy Blomfield as group chief operating officer. He joins from from …

Appointment

Service Insight: Producing a better sales forecast

March 21, 2011
Sales and Marketing Dr Hazel Rudge-Pickard, Pickard-Smith Consulting, Service Insight, forecasting

SERVICE INSIGHT

Feature

Financial Reporting – it’s all a foreign language… literally!

March 18, 2011
Business Services Audits, Business, Financial, Languages, Reports, Services, TranslateMedia, tax, translation

Over the last two decades technology has allowed companies to greatly increase their global reach. Within the pharmaceutical sector it …

Feature
Thought Leadership

NHS Confederation: value-based pricing could increase NHS costs

March 18, 2011
Sales and Marketing NHS Confederation, PPRS, Pharmaceutical Price Regulation Scheme, UK drug pricing, VBP, value-based pricing

Government plans to introduce value-based pricing in the UK could increase the NHS drugs bill without improving the effectiveness of …

News
Obesity

Takeda obesity drug falters at phase II

March 18, 2011
Research and Development Alli, Amylin, Contrave, Meridia, Qnexa, Takeda, Xenical, lorcaserin, metreleptin, obesity, pramlintide

Yet another investigational drug appears to have faltered on the rocky path to develop anti-obesity treatments. Takeda Pharmaceutical Company and …

News

GSK in manufacturing research collaboration with university

March 18, 2011
Manufacturing and Production Advanced Manufacturing, Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, EPSRC fund, GSK, GlaxoSmithKline, Manufacturing Fellowships, academic research, pharma manufacturing

Research into a cutting-edge area of pharmaceutical manufacturing in the UK is to be supported by a new £51 million …

News
efpia_lif_richard_bergstrom

Richard Bergström takes DG role at EFPIA

March 18, 2011
Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing

European pharma industry association EFPIA has appointed Richard Bergström as its new director general. He takes over from Brian Ager, …

Appointment

Novartis plans Q2 filing for blood cancer drug

March 17, 2011
Sales and Marketing COMFORT-II trial, INC424, Incyte, JAK, Janus kinase inhibitor, Novartis, blood cancer, cancer drug, myelofibrosis, ruxolitinib

Novartis will file ruxolitinib for worldwide regulatory approval in the second quarter after the cancer drug met its primary endpoint …

News

Biotech lobbies for further UK tax breaks

March 17, 2011
Research and Development BIA, R&D tax credits, biotech

Biotech companies are calling on Chancellor George Osborne to provide extra incentives for research in his forthcoming Budget. The budget …

News
Association of the British Pharmaceutical Industry

Pharma industry wary of UK drug pricing changes

March 17, 2011
Sales and Marketing ABPI, National Voices, PPRS, Pharmaceutical Price Regulation Scheme, Simon Jose, UK drug pricing, VBP, value-based pricing

The ABPI wants the current drug pricing system to remain, but has welcomed government proposals to take a broader view …

News
Japanese rescue workers

Japan’s pharma industry pledges to maintain medicines supply

March 17, 2011
Sales and Marketing Astellas, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Japan, earthquake

Pharmaceutical firms in Japan have escaped the very worst of the devastation caused by the earthquake and tsunami, and have …

News
merck_sharp_dohme_deepak_khanna

MSD’s Deepak Khanna to chair American Pharmaceutical Group

March 17, 2011
Research and Development, Sales and Marketing American Pharmaceutical Group, Deepak Khanna, MSD, merck sharp and dohme

Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group. The APG …

Appointment
novartis

Novartis to close UK manufacturing site, research downsized

March 16, 2011
Research and Development Horsham, Novartis, respiratory

Novartis is to close its manufacturing site in Horsham, West Sussex, but will retain its work in respiratory research at …

News
Novarits

Novartis to close UK research site

March 16, 2011
Research and Development Horsham, Novartis, job cuts, pharma job cuts

[UPDATE: Novartis has confirmed it will close its manufacturing site in Horsham, but continue to conduct respiratory research at the site …

News
Novo Nordisk's type II diabetes drug Victoza (liraglutide)

Novo’s diabetes drug Victoza approved in China

March 16, 2011
Sales and Marketing Glucagon-Like Peptide-1, Novo Nordisk, Victoza, diabetes in China, liraglutide, type 2 diabetes

Novo Nordisk’s injectable diabetes drug Victoza has been given regulatory approval in China. The Chinese State Food and Drug Administration …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026